Cargando…

Antihyperglycemic Medications: A Claims-Based Estimate of First-line Therapy Use Prior to Initialization of Second-line Medications

OBJECTIVE: The American Diabetes Association recommends metformin as first-line therapy for type 2 diabetes. However, nonadherence to antihyperglycemic medication is common, and a clinician could confuse nonadherence with pharmacologic failure, potentially leading to premature prescribing of second-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tseng, Yi-Ju, Steinberg, Gregory, Fox, Kathe P., Armstrong, Joanne, Mandl, Kenneth D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2017
Materias:	Epidemiology/Health Services Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652584/ https://www.ncbi.nlm.nih.gov/pubmed/28903978 http://dx.doi.org/10.2337/dc17-0213

Ejemplares similares

Correlates of second-line type 2 diabetes medication selection in the USA
por: Ackermann, Ronald T, et al.
Publicado: (2017)

Estimating the effects of second-line therapy for type 2 diabetes mellitus: retrospective cohort study
por: Gottlieb, Assaf, et al.
Publicado: (2017)

Determinants of Adherence to Diabetes Medications: Findings From a Large Pharmacy Claims Database
por: Kirkman, M. Sue, et al.
Publicado: (2015)

What Is Valued Most by Patients With Type 2 Diabetes Mellitus When Selecting Second-Line Antihyperglycemic Medications in China
por: Liu, Shimeng, et al.
Publicado: (2021)

Prior Glucose-Lowering Medication Use and 30-Day Outcomes Among 64,892 Veterans With Diabetes and COVID-19
por: Wander, Pandora L., et al.
Publicado: (2021)

Data concordance between ESRD Medical Evidence Report and Medicare claims: is there any improvement?
por: Mu, Yi, et al.
Publicado: (2018)

Racial inequities in second-line treatment and overall survival among patients with metastatic breast cancer
por: Whitaker, Kristen D., et al.
Publicado: (2022)

The Royal Naval Medical Service: Its Claims and Advantages
Publicado: (1916)

Medical expenditure trajectory and HbA1c progression prior to and after clinical diagnosis of type 2 diabetes in a commercially insured population in the USA
por: Pagán, Lorissa, et al.
Publicado: (2023)

Antihyperglycemic Medications and Cardiovascular Risk Reduction
por: Anderson, Sarah L, et al.
Publicado: (2017)

Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa
por: Onoya, Dorina, et al.
Publicado: (2017)

Clinical effectiveness of second-line antihyperglycemic drugs on major adverse cardiovascular events: An emulation of a target trial
por: Siriyotha, Sukanya, et al.
Publicado: (2023)

Validity assessment of self-reported medication use by comparing to pharmacy insurance claims
por: Fujita, Misuzu, et al.
Publicado: (2015)

Estimating the prevalence and incidence of type 2 diabetes using population level pharmacy claims data: a cross-sectional study
por: Sinnott, Sarah-Jo, et al.
Publicado: (2017)

Medication Utilization in Children Born Preterm in the First Two Years of Life
por: Levin, Jonathan C, et al.
Publicado: (2021)

A prediction model to estimate completeness of electronic physician claims databases
por: Lix, Lisa M, et al.
Publicado: (2015)

Patient-initiated second medical consultations—patient characteristics and motivating factors, impact on care and satisfaction: a systematic review
por: Greenfield, Geva, et al.
Publicado: (2021)

The Darkening Cloud of Diabetes: Do trends in cardiovascular risk management provide a silver lining?
por: Eurich, Dean T., et al.
Publicado: (2008)

Retrospective analysis of medical malpractice claims in tertiary hospitals of China: the view from patient safety
por: Li, Heng, et al.
Publicado: (2020)

Future number of people with diagnosed type 1 diabetes in Germany until 2040: an analysis based on claims data
por: Voeltz, Dina, et al.
Publicado: (2023)

Initiating second-line antidiabetic medication among older adults with type 2 diabetes on Metformin
por: DeCarlo, Kristen, et al.
Publicado: (2022)

An evaluation of prescribing trends and patterns of claims within the Preferred Drugs Initiative in Ireland (2011–2016): an interrupted time-series study
por: McDowell, Ronald, et al.
Publicado: (2018)

Medication reconciliation as a medication safety initiative in Ethiopia: a study protocol
por: Mekonnen, Alemayehu B, et al.
Publicado: (2016)

Exploring geographic variation of and influencing factors for utilization of four diabetes management measures in Swiss population using claims data
por: Wei, Wenjia, et al.
Publicado: (2020)

Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure
por: Shroufi, Amir, et al.
Publicado: (2019)

Prevalence of multimorbidity and its associations with hospitalisation or death in Japan 2014–2019: a retrospective cohort study using nationwide medical claims data in the middle-aged generation
por: Saito, Yoshiyuki, et al.
Publicado: (2023)

Body mass index is associated with the maternal lines but height is heritable across family lines in the Lifeways Cross-Generation Cohort Study
por: Kelly, Gabrielle E, et al.
Publicado: (2014)

Can purchasing information be used to predict adherence to cardiovascular medications? An analysis of linked retail pharmacy and insurance claims data
por: Krumme, Alexis A, et al.
Publicado: (2016)

Vocational and psychosocial predictors of medical negligence claims among Australian doctors: a prospective cohort analysis of the MABEL survey
por: Bradfield, Owen M, et al.
Publicado: (2022)

Process quality of diabetes care under favorable access to healthcare: a 2-year longitudinal study using claims data in Japan
por: Tanaka, Hirokazu, et al.
Publicado: (2016)

Second-generation antipsychotic medications and risk of chronic kidney disease in schizophrenia: population-based nested case–control study
por: Wang, Hsien-Yi, et al.
Publicado: (2018)

Nationally Representative Medical Costs of Diabetes by Time Since Diagnosis
por: Trogdon, Justin G., et al.
Publicado: (2008)

Antidiabetic medication use during pregnancy: an international utilization study
por: Cesta, Carolyn E, et al.
Publicado: (2019)

Injury epidemiology of workers by age, sex and industrial classification using the medical claim data of National Health Insurance in South Korea, 2012–2015: a population-based retrospective study
por: Lim, Sung-Shil, et al.
Publicado: (2019)

Medication adherence and glycemic control among newly diagnosed diabetes patients
por: Lin, Lee-Kai, et al.
Publicado: (2017)

Ethnicity and Second-Line Antihypertensive Medication Response in the ASCOT Trial
por: Davis, Jason T., et al.
Publicado: (2010)

Cohort Study of Antihyperglycemic Medication and Pancreatic Cancer Patients Survival
por: Dulskas, Audrius, et al.
Publicado: (2020)

Mining treatment patterns of glucose-lowering medications for type 2 diabetes in the Netherlands
por: van den Heuvel, Jan Maurik, et al.
Publicado: (2020)

Treatment pattern trends of medications for type 2 diabetes in British Columbia, Canada
por: Carney, Greg, et al.
Publicado: (2022)

Racial Comparisons of Diabetes Care and Intermediate Outcomes in a Patient-Centered Medical Home
por: Simonetti, Joseph A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6bu87nc4ncvpjrhgo356rkcf3b